-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, S2sonE6eGpx0HnpPVzybTSBEd7X/gPh+AMMv1vzekv93wwnLwhcKSCLCevthUevc JK24zBlOyNwvfvU29uCCEg== 0001202291-07-000093.txt : 20070418 0001202291-07-000093.hdr.sgml : 20070418 20070418160728 ACCESSION NUMBER: 0001202291-07-000093 CONFORMED SUBMISSION TYPE: SC 13G PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20070418 DATE AS OF CHANGE: 20070418 GROUP MEMBERS: HEALTHINVEST GLOBAL LONG/SHORT FUND SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: MEDTOX SCIENTIFIC INC CENTRAL INDEX KEY: 0000739944 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071] IRS NUMBER: 953863205 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G SEC ACT: 1934 Act SEC FILE NUMBER: 005-37329 FILM NUMBER: 07773582 BUSINESS ADDRESS: STREET 1: 402 WEST COUNTY ROAD D CITY: ST PAUL STATE: MN ZIP: 55112 BUSINESS PHONE: 6126367466 MAIL ADDRESS: STREET 1: 402 WEST COUNTY ROAD D CITY: ST PAUL STATE: MN ZIP: 55112 FORMER COMPANY: FORMER CONFORMED NAME: EDITEK INC DATE OF NAME CHANGE: 19940902 FORMER COMPANY: FORMER CONFORMED NAME: ENVIRONMENTAL DIAGNOSTICS INC DATE OF NAME CHANGE: 19920703 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: Healthinvest Partners AB CENTRAL INDEX KEY: 0001381843 IRS NUMBER: 000000000 STATE OF INCORPORATION: V7 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G BUSINESS ADDRESS: STREET 1: ARSENALSGATAN 4 CITY: STOCKHOLM STATE: V7 ZIP: SE-111 47 BUSINESS PHONE: 46 08 440 38 31 MAIL ADDRESS: STREET 1: ARSENALSGATAN 4 CITY: STOCKHOLM STATE: V7 ZIP: SE-111 47 SC 13G 1 form13g.htm FORM 13G FILED BY HEALTHINVEST PARTNERS AB, ISSUER MEDTOX SCIENTIFIC, INC. FILED 2007-04-18 form13g.htm
OMB APPROVAL
OMB Number: 3235-0145
Expires: February 28, 2009
Estimated average burden
Hours per response 10.4


UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G
Under the Securities Exchange Act of 1934
(Amendment No. __)*


Medtox Scientific, Inc.
-------------------------------------------------------------------------------
(Name of Issuer)


Common Stock
-------------------------------------------------------------------------------
(Title of Class of Securities)


584977201
----------------------------------------
(CUSIP Number)

April 13, 2007
-------------------------------------------------------------------------------
(Date of Event Which Requires Filing of this Statement

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

[ ] Rule 13d-1(b)

[X] Rule 13d-1(c)

[_] Rule 13d-1(d)

*The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the notes).

Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMD control number.

SEC 1745 (3-06)

Page 1 of 6 pages
 


------------------------------------------------
CUSIP No. 584977201
------------------------------------------------
 
---------------------------------------------------------------------------------------------------------------------------------
1       Name of Reporting Persons
            I.R.S. Identification Nos. of above persons (entities only)
 
      Healthinvest Partners AB
---------------------------------------------------------------------------------------------------------------------------------
2       Check the Appropriate Box if a Member of a Group (See Instruction)
 
(a) [   ]
(b) [X]
---------------------------------------------------------------------------------------------------------------------------------
3       SEC Use Only
---------------------------------------------------------------------------------------------------------------------------------
4       Citizen or Place of Organization
 
Sweden
---------------------------------------------------------------------------------------------------------------------------------
Number of  5    Sole Voting Power        494,719
-----------------------------------------------------------------------------------------------------------------
Shares
 
Beneficially         6    Shared Voting Power        0
----------------------------------------------------------------------------------------------------------------
Owned by
 
Each   7    Sole Dispositive Power      494,719
----------------------------------------------------------------------------------------------------------------
Reporting
 
Person With:        8    Shared Dispositive Power     0
---------------------------------------------------------------------------------------------------------------------------------
 
9   Aggregate Amount Beneficially Owned by Each Reporting Person
 
494,719
---------------------------------------------------------------------------------------------------------------------------------
10   Check if the Aggregate Amount in Row (9) Excludes Certain Shares
(See Instructions)       [ ]
---------------------------------------------------------------------------------------------------------------------------------
11   Percent of Class Represented by Amount in Row (9)
 
6.0%
---------------------------------------------------------------------------------------------------------------------------------
12   Type of Reporting Person (See Instructions)
 
IA, HC
---------------------------------------------------------------------------------------------------------------------------------

Page 2 of 6 pages
 


------------------------------------------------
CUSIP No. 584977201
------------------------------------------------
 
---------------------------------------------------------------------------------------------------------------------------------
1       Name of Reporting Persons
I.R.S. Identification Nos. of above persons (entities only)
 
HealthInvest Global Long/Short Fund
---------------------------------------------------------------------------------------------------------------------------------
2       Check the Appropriate Box if a Member of a Group (See Instruction)
 
(a) [ ]
(b) [X]
---------------------------------------------------------------------------------------------------------------------------------
3       SEC Use Only
---------------------------------------------------------------------------------------------------------------------------------
4       Citizen or Place of Organization
 
Sweden
---------------------------------------------------------------------------------------------------------------------------------
Number of  5    Sole Voting Power            0
-----------------------------------------------------------------------------------------------------------------
Shares
 
Beneficially        6    Shared Voting Power        494,719
----------------------------------------------------------------------------------------------------------------
Owned by
 
Each                    7    Sole Dispositive Power           0
-----------------------------------------------------------------------------------------------------------------
Reporting
 
Person With:      8    Shared Dispositive Power            494,719
---------------------------------------------------------------------------------------------------------------------------------
 
9   Aggregate Amount Beneficially Owned by Each Reporting Person
 
494,719
---------------------------------------------------------------------------------------------------------------------------------
10     Check if the Aggregate Amount in Row (9) Excludes Certain Shares
(See Instructions)       [ ]
---------------------------------------------------------------------------------------------------------------------------------
11     Percent of Class Represented by Amount in Row (9)
 
6.0%
---------------------------------------------------------------------------------------------------------------------------------
12     Type of Reporting Person (See Instructions)
 
OO
---------------------------------------------------------------------------------------------------------------------------------

Page 3 of 6 pages
 


Item 1(a)
Name of Issuer
 
Medtox Scientific, Inc.
   
Item 1(b)
Address of Issuers Principal Executive Offices:
 
402 West County Road D
 
St. Paul, Minnesota 55112
   
Item 2(a)
Name of Persons Filing:
 
Healthinvest Partners AB and HealthInvest Global Long/Short Fund
 
Healthinvest Partners AB is the investment advisor and control person of HealthInvest Global Long/Short Fund, a security holder of the issuer. HealthInvest Global Long/Short Fund is a specialty fund organized pursuant to the Swedish Mutual Funds Act.
   
Item 2(b)
Address of Principal Business Office or, if none Residence:
 
Arsenalsgatan 4
 
SE-111 47 Stockholm
 
Sweden
   
Item 2(c)
Citizenship:
 
See the response(s) to Item 4 on the attached cover page(s).
   
Item 2(d)
Title of Class of Securities:
 
Common Stock
   
Item 2(e)
CUSIP Number:
 
584977201
   
Item 3
If this statement is filed pursuant to Rules 13d-1(b) or 13d-2(b) or (c), check whether the person filing is a:
 
Not Applicable


Page 4 of 6 pages
 


Item 4             Ownership
 
(a)   Amount Beneficially owned:
 See the response(s) to Item 9 on the attached cover page(s).
 
(b)   Percent of Class:
 See the response(s) to Item 11 on the attached cover page(s).
 
(c)   Number of shares as to which the person has:
 
(i)   Sole power to vote or to direct the vote:
See the response(s) to Item 5 on the attached cover page(s).
 
(ii)        Shared power to vote or to direct the vote:
See the response(s) to Item 6 on the attached cover page(s).
 
(iii)       Sole power to dispose or direct the disposition of:
See the response(s) to Item 7 on the attached cover page(s).
 
(iv)       Shared power to dispose or direct the disposition of:
See the response(s) to Item 8 on the attached cover page(s).
 
Item 5             Ownership of five percent or less of a class.
Not Applicable
 
Item 6             Ownership of more than five percent on behalf of another person.
Not Applicable
 
Item 7          Identification and Classification of the Subsidiary which acquired the Security being reported by the Parent Holding Company.
Not Applicable
 
Item 8             Identification and Classification of Members of the Group.
Not Applicable
 
Item 9             Notice of Dissolution of Group.
Not Applicable
 
Item 10           Certification
By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect.

Page 5 of 6 pages
 

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.


DATE:  April 18, 2007
                HEALTHINVEST PARTNERS AB
 
                By: /s/ ANDERS HALLBERG
 
                Name: Anders Hallberg
                Title: Managing Director and CEO
 
                HEALTHINVEST GLOBAL LONG/SHORT FUND
 
                By: /s/ Anders Hallberg
                Title: CEO of Managing Company
 
 
Page 6 of 6 pages
 -----END PRIVACY-ENHANCED MESSAGE-----